Barbara Zangerl is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of genetics, particularly in understanding progressive rod-cone degeneration in dogs. With a total of 4 patents, her work has advanced the knowledge and testing methods related to this genetic condition.

Latest Patents

Zangerl's latest patents include groundbreaking methods for identifying genetic predispositions in dogs. One of her notable patents is the identification of the gene and mutation responsible for progressive rod-cone degeneration in dogs. This patent provides tools and methods for determining whether a dog is genetically normal, a carrier, or affected by this condition. The method is based on detecting a transversion from G to A at a specific nucleotide position. Another significant patent is a method for identifying progressive rod-cone degeneration in dogs, which involves analyzing nucleic acids to determine the presence of prcd polymorphisms.

Career Highlights

Barbara Zangerl is affiliated with Cornell University, where she conducts her research and develops her innovative methods. Her work has been instrumental in enhancing the understanding of genetic disorders in canines, contributing to better health outcomes for affected dogs.

Collaborations

Zangerl has collaborated with notable colleagues such as Gregory M Acland and Susan Pearce-Kelling. These collaborations have further enriched her research and expanded the impact of her inventions in the field of veterinary genetics.

Conclusion

Barbara Zangerl's contributions to canine genetic research have paved the way for advancements in understanding and diagnosing progressive rod-cone degeneration. Her innovative methods and dedication to her work continue to benefit the field and improve the lives of dogs affected by genetic disorders.